Drugs / VitroGro® ECM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01982318 Comparator | Jan 2017 → Jun 2018 | ulcer of lower limbs | Tissue Therapies Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VitroGro ECM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01982318 ↗ |
| Modality | Protein / enzyme biologic | “synthetic extracellular matrix (ECM) protein formulation” NCT01982318 ↗ |
| Route | Topical | “A topical application of synthetic extracellular matrix (ECM) protein formulation to the wound bed” NCT01982318 ↗ |